 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Current Price	$21.01
Prev Close	$22.02
Open	$21.01
Dividend Yield	0.00%
50-Day Moving Average	$25.95
Beta	0.00
Avg. Volume	1,308.05
PE Ratio	-37.67

52-Week High	$48.29
52-Week Low	$22.00
Market Capitalization	$286.54M
EPS	-$0.5846
Price to Book	16.79
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-61.98

RGC Regencell Bioscience Holdings Ltd

About

Feed

Fundamentals

News